A federal committee has voted in favor of granting emergency authorization to Johnson & Johnson’s one-shot COVID-19 vaccine.
If authorized for emergency use by @US_FDA, it could speed up vaccine distribution and help alleviate equity concerns. bit.ly/2P5yLHt
If authorized for emergency use by @US_FDA, it could speed up vaccine distribution and help alleviate equity concerns. bit.ly/2P5yLHt
How is Johnson & Johnson’s vaccine different than Moderna and Pfizer’s?
— It’s simpler to produce because it requires only one dose.
— Experts say it might be easier to give to people who don’t have consistent access to the health care system. bit.ly/2P5yLHt
— It’s simpler to produce because it requires only one dose.
— Experts say it might be easier to give to people who don’t have consistent access to the health care system. bit.ly/2P5yLHt
Pending emergency authorization, the White House has said it has 3-4 million doses of Johnson & Johnson vaccines ready to send states within the next week.
Currently, states are administering a rolling average of 1.7M vaccines a day from Moderna and Pfizer’s two-shot regimens.
Currently, states are administering a rolling average of 1.7M vaccines a day from Moderna and Pfizer’s two-shot regimens.
The United States has secured enough vaccines from Moderna and Pfizer to vaccinate the entire country by the end of July.
A third vaccine could speed things up.
More from @Shefalil: bit.ly/2P5yLHt
A third vaccine could speed things up.
More from @Shefalil: bit.ly/2P5yLHt
• • •
Missing some Tweet in this thread? You can try to
force a refresh
